The most common reason for early discontinuation was the occurrence of an adverse event, with a numerically higher percentage in the daptomycin group [10/15 (67%) versus 5/9 (56%); P = 0.68] that did not reach statistical significance.
← all excerpts
Adverse events leading to discontinuation of daptomycin versus vancomycin in outpatient parenteral antimicrobial therapy: a retrospective cohort study.
1
—
—